Tokyo, Japan

Gilbu Soe

USPTO Granted Patents = 7 


Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Inba, JP (1996)
  • Tokyo, JP (1998 - 2003)

Company Filing History:


Years Active: 1996-2003

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Gilbu Soe

Introduction: Gilbu Soe, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of medical technology. With a total of seven patents to his name, his work primarily focuses on innovative solutions for promoting cellular adhesion and advancing injury treatment.

Latest Patents: Among his most recent inventions are groundbreaking patents that include a hemostatic agent that aids in injury treatment. This agent comprises an alkali or alkali earth metal salt of carboxymethyl cellulose and a pharmaceutically acceptable carrier. Another notable patent is the "Method of Curing an Injury to a Skin Surface," which also employs a similar formulation to enhance healing and cellular adhesion.

Career Highlights: Gilbu Soe has held significant roles in reputable companies, including Hogy Medical Co., Ltd. and Iatron Laboratories Inc. His expertise in developing medical solutions has driven him to innovate continuously, making positive impacts in healthcare.

Collaborations: Throughout his career, Gilbu has collaborated with esteemed colleagues such as Motonori Aoshima and Koichi Takada. These partnerships have allowed for the merging of ideas and expertise, ultimately enhancing the quality and precision of their innovations.

Conclusion: Gilbu Soe stands out as a remarkable inventor whose work continues to shape the landscape of medical technology in Japan. With a commitment to addressing key challenges in healthcare, his patents reflect a dedication to improving patient outcomes and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…